phosphatidylcholines has been researched along with losartan in 4 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (losartan) | Trials (losartan) | Recent Studies (post-2010) (losartan) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 7,231 | 1,245 | 2,118 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | losartan (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 9.01 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.882 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.019 | |
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.0018 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.019 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0247 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0234 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.0032 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.047 | |
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | 0.025 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0118 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.019 | |
| Platelet glycoprotein VI | Homo sapiens (human) | 4 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.1481 | |
| Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.2884 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choy, PC; Hatch, GM; Kroeger, EA; Lee, D; Man, RY | 2 |
| Alvarez, S; Carrizo, L; Manucha, W; Oliveros, L; Valles, P | 1 |
| Hodzic, A; Mavromoustakos, T; Pabst, G; Rappolt, M; Zoumpoulakis, P | 1 |
4 other study(ies) available for phosphatidylcholines and losartan
| Article | Year |
|---|---|
On the mechanism of the losartan-mediated inhibition of phosphatidylcholine biosynthesis in H9c2 cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cell Line; Cell Membrane; Choline; Cytosol; Imidazoles; Immunoblotting; Kinetics; Losartan; Phosphatidylcholines; Pyridines; Tetrazoles; Tritium | 1997 |
Losartan-mediated regulation of phospholipid biosynthesis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Line; Choline; Dose-Response Relationship, Drug; Losartan; Myocardium; Phosphatidylcholines; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 1997 |
Effect of losartan pretreatment on kidney lipid content after unilateral obstruction in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cholesterol; Fatty Acids; Female; Gene Expression Regulation; Kidney Cortex; Lipid Metabolism; Lipids; Losartan; Phosphatidylcholines; Phosphatidylethanolamines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Sphingomyelins; Ureteral Obstruction | 2005 |
Losartan's affinity to fluid bilayers modulates lipid-cholesterol interactions.
Topics: Cholesterol; Dimyristoylphosphatidylcholine; Lipid Bilayers; Losartan; Membrane Microdomains; Phosphatidylcholines | 2012 |